Plain-English translation of NCT05977088 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called repetitive Transcranial Magnetic Stimulation (rTMS) for people with Alzheimer's disease. rTMS uses magnetic pulses to gently stimulate specific areas of the brain that control thinking and memory. The researchers want to understand whether this treatment can improve cognitive function and reduce some of the harmful inflammation and damage that happens in Alzheimer's.
Current medications alone are not enough to effectively treat Alzheimer's disease. This trial exists because researchers want to explore whether non-medication approaches like brain stimulation could offer a new way to help patients, similar to how it has shown promise in other brain and psychiatric conditions.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for brain imaging and thinking tests before treatment begins. Then you would receive five days of magnetic brain stimulation treatment, with two sessions per day—each session takes about 30 minutes. Brain activity recordings would be taken before treatment, during the sessions, and one week after treatment ends. You would also complete memory and thinking tests before and after to measure any changes. A control group would receive the same visits and tests but with a sham (inactive) version of the treatment so researchers can compare results.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Turkey (Türkiye)